855676C

17:0 Lyso PC

1-heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine, chloroform

• Synonym(e): 1-heptadecanoyl-sn-glycero-3-phosphocholine; PC(17:0/0:0)
• Empirische Formel (Hill-System): C₂₅H₅₂NO₇P
• CAS-Nummer: 50930-23-9
• Molekulargewicht: 509.66
• MDL-Nummer: MFCD00133433
• UNSPSC-Code: 51191904
• NACRES: NA.25

Eigenschaften

• Assay: >99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)
• Form: liquid
• Verpackung: pkg of 1 × 2.5 mL (855676C-25mg); pkg of 2 × 4 mL (855676C-200mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 855676C
• Konzentration: 10 mg/mL (855676C-25mg); 25 mg/mL (855676C-200mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [P](=O)([O-])(OC[C@H](O)COC(=O)CCCCCCCCCCCCCCCC)OCC[N+](C)(C)C
• InChI: 1S/C25H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-25(28)31-22-24(27)23-33-34(29,30)32-21-20-26(2,3)4/h24,27H,5-23H2,1-4H3/t24-/m1/s1
• InChIKey: SRRQPVVYXBTRQK-XMMPIXPASA-N

Beschreibung

Anwendung

17:0 Lyso PC has been used for the extraction of lipids from the blood samples.

Verpackung

5 mL Clear Glass Sealed Ampule (855676C-200mg)

5 mL Clear Glass Sealed Ampule (855676C-25mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• P-Sätze: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system, Liver,Kidney
• WGK: WGK 3